Mangalam Drugs And Stock Shares Outstanding
| MANGALAM | 122.13 15.45 14.48% |
Mangalam Drugs And fundamentals help investors to digest information that contributes to Mangalam Drugs' financial success or failures. It also enables traders to predict the movement of Mangalam Stock. The fundamental analysis module provides a way to measure Mangalam Drugs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mangalam Drugs stock.
As of December 1, 2024, Common Stock Shares Outstanding is expected to decline to about 16 M. Mangalam | Shares Outstanding |
Mangalam Drugs And Company Shares Outstanding Analysis
Mangalam Drugs' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Mangalam Drugs Shares Outstanding | 15.83 M |
Most of Mangalam Drugs' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mangalam Drugs And is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Mangalam Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Mangalam Drugs And has 15.83 M of shares currently outstending. This is 91.23% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The shares outstanding for all India stocks is 97.23% higher than that of the company.
Mangalam Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mangalam Drugs' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mangalam Drugs could also be used in its relative valuation, which is a method of valuing Mangalam Drugs by comparing valuation metrics of similar companies.Mangalam Drugs is currently under evaluation in shares outstanding category among its peers.
Mangalam Fundamentals
| Return On Equity | -0.0631 | ||||
| Return On Asset | 0.005 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 2.6 B | ||||
| Shares Outstanding | 15.83 M | ||||
| Shares Owned By Insiders | 54.58 % | ||||
| Price To Book | 1.31 X | ||||
| Price To Sales | 0.54 X | ||||
| Revenue | 3.67 B | ||||
| Gross Profit | 1.17 B | ||||
| EBITDA | 139.86 M | ||||
| Net Income | (90.72 M) | ||||
| Cash And Equivalents | 917.4 M | ||||
| Total Debt | 1.07 B | ||||
| Book Value Per Share | 85.79 X | ||||
| Cash Flow From Operations | 39.13 M | ||||
| Earnings Per Share | (4.03) X | ||||
| Number Of Employees | 432 | ||||
| Beta | 0.75 | ||||
| Market Capitalization | 1.69 B | ||||
| Total Asset | 3.34 B | ||||
| Retained Earnings | 867.33 M | ||||
| Working Capital | 119.39 M | ||||
| Net Asset | 3.34 B |
About Mangalam Drugs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mangalam Drugs And's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mangalam Drugs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mangalam Drugs And based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Mangalam Stock
Mangalam Drugs financial ratios help investors to determine whether Mangalam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mangalam with respect to the benefits of owning Mangalam Drugs security.